ID   MEL4478D
AC   CVCL_C7WA
SY   4478D mel
DR   Wikidata; Q123033035
RX   PubMed=22207316;
RX   PubMed=31817719;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=22207316; DOI=10.1007/s00262-011-1179-z; PMCID=PMC3401505;
RA   Mazzarella, Tonia
RA   Cambiaghi, Valeria
RA   Rizzo, Nathalie
RA   Pilla, Lorenzo
RA   Parolini, Danilo
RA   Orsenigo, Elena
RA   Colucci, Annalisa
RA   Modorati, Giulio
RA   Doglioni, Claudio
RA   Parmiani, Giorgio
RA   Maccalli, Cristina
RT   "Ex vivo enrichment of circulating anti-tumor T cells from both
RT   cutaneous and ocular melanoma patients: clinical implications for
RT   adoptive cell transfer therapy.";
RL   Cancer Immunol. Immunother. 61:1169-1182(2012).
//
RX   PubMed=31817719; DOI=10.3390/cancers11121963; PMCID=PMC6966589;
RA   Terzuoli, Erika
RA   Bellan, Cristiana
RA   Aversa, Sara
RA   Ciccone, Valerio
RA   Morbidelli, Lucia
RA   Giachetti, Antonio
RA   Donnini, Sandra
RA   Ziche, Marina
RT   "ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem
RT   cell expansion, impairing immune surveillance through enhanced PD-L1
RT   output.";
RL   Cancers (Basel) 11:1963.1-1963.23(2019).
//